Previous close | 10.10 |
Open | 10.10 |
Bid | 4.20 |
Ask | 8.80 |
Strike | 340.00 |
Expiry date | 2023-08-18 |
Day's range | 10.10 - 10.10 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
The Cooper Companies (COO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year.
SAN RAMON, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled to begin at 2:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be available on the sa
XRAY vs. COO: Which Stock Is the Better Value Option?
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -51.92% and 65.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SAN RAMON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today released its 2022 Environmental, Social, and Governance (ESG) Report. It highlights the company's progress on social and environmental issues most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities. In 2022, CooperCompanies manufactured a record number of products while reducing greenhouse gas (GHG) emissions by more than 7%. A big contributor to t
Henry Schein (HSIC) delivered earnings and revenue surprises of -2.42% and 1.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
XRAY vs. COO: Which Stock Is the Better Value Option?
Cardinal (CAH) delivered earnings and revenue surprises of 17.57% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SAN RAMON, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report second quarter 2023 financial results on Thursday, June 1, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7116518. A simultaneous audio webcast can be accessed on CooperCompanies’ investor relations websi
West Pharmaceutical Services, The Cooper Companies and Henry Schein have been highlighted in this Industry Outlook article.
Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
Investors continue to feel optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.
XRAY vs. COO: Which Stock Is the Better Value Option?
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cooper Companies fair value estimate is US$329 Current share...
Investors are optimistic about Patterson Companies' (PDCO) strong product line.
Here is how Clene Inc. (CLNN) and The Cooper Companies (COO) have performed compared to their sector so far this year.
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.
Key Insights Cooper Companies' Annual General Meeting to take place on 15th of March CEO Al White's total compensation...